Shurzinske, L.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels

Petar Alaupovic, Therese Heinonen, Linda Shurzinske, Donald M Black

Journal:

Atherosclerosis

Year:

1997

Language:

english

File:

PDF, 336 KB

english, 1997

2

To adjust or not to adjust for baseline when analyzing repeated binary responses? The case of complete data when treatment comparison at study end is of interest

Jiang, Honghua, Kulkarni, Pandurang M., Mallinckrodt, Craig H., Shurzinske, Linda, Molenberghs, Geert, Lipkovich, Ilya

Journal:

Pharmaceutical Statistics

Year:

2015

Language:

english

File:

PDF, 722 KB

english, 2015

3

Covariate Adjustment for Logistic Regression Analysis of Binary Clinical Trial Data

Jiang, Honghua, Kulkarni, Pandurang M, Mallinckrodt, Craig H, Shurzinske, Linda, Molenberghs, Geert, Lipkovich, Ilya

Journal:

Statistics in Biopharmaceutical Research

Year:

2016

Language:

english

File:

PDF, 786 KB

english, 2016

4

Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: A drug-withdrawal study

Mary Alice Miller, Michele Texter, Anita Gmerek, Jeffery Robbins, Linda Shurzinske, David Canter

Journal:

Cardiovascular Drugs and Therapy

Year:

1994

Language:

english

File:

PDF, 560 KB

english, 1994

5

The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study

Therese M. Heinonen, Evan Stein, Stuart R. Weiss, James M. McKenney, Michael Davidson, Linda Shurzinske, Donald M. Black

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 640 KB

english, 1996

6

Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: A randomized, placebo-controlled study

Helmut G. Schrott, Howard Knapp, Michele Davila, Linda Shurzinske, Donald Black

Journal:

American Heart Journal

Year:

2000

Language:

english

File:

PDF, 86 KB

english, 2000

7

2.P.17 Effectiveness of atorvastatin in treating patients to LDL-C goals compared with lovastatin, pravastatin and simvastatin

J. Nawrocki, L. Shurzinske, D.M. Black

Journal:

Atherosclerosis

Year:

1997

Language:

english

File:

PDF, 185 KB

english, 1997

8

2.P.15 Two-year comparison of safety and efficacy of atorvastatin and lovastatin

R.G. Bakker-Arkema, L. Shurzinske, M. Davidson, J. McKenney, E. Stein, H. Schrott, D.M. Black

Journal:

Atherosclerosis

Year:

1997

Language:

english

File:

PDF, 183 KB

english, 1997

9

Efficacy and safety of atorvastatin in the treatment of patients with hypertriglyceridemia of various phenotypes

T.K. Peters, M. Rieger, L. Shurzinske, S. Myers, J.W. Nawrocki

Journal:

Atherosclerosis

Year:

1999

Language:

english

File:

PDF, 151 KB

english, 1999

10

CANADA.

Bakker-Arkema, R., Davidson, M., Goldstein, R., Davignon, J., Isaacsohn, J., Weiss, S., Keilson, L., Brown, V., Miller, V., Shurzinske, L., Black, D.

Journal:

Year:

1919

Language:

english

File:

PDF, 207 KB

english, 1919

11

MEDICAL SOCIETY OF LONDON.

Bakker-Arkema, R., Davidson, M., Goldstein, R., Davignon, J., Isaacsohn, J., Weiss, S., Keilson, L., Brown, V., Miller, V., Shurzinske, L., Black, D.

Journal:

Year:

1887

Language:

english

File:

PDF, 441 KB

english, 1887

12

Atorvastatin, a new HMG-CoA reductase inhibitor (HMGRI), is safe and effective in hypertriglyceridemic patients

Bakker-Arkema, R., Davidson, M., Goldstein, R., Davignon, J., Isaacsohn, J., Weiss, S., Keilson, L., Brown, V., Miller, V., Shurzinske, L., Black, D.

Journal:

Atherosclerosis

Year:

1994

Language:

english

File:

PDF, 157 KB

english, 1994

13

Comparison of atorvastatin, a new HMG-CoA reductase inhibitor, with pravastatin and simvastatin

Seiler, K.-U., Wolffenbu¨ttel, B.H.R., Mahla, G., Mu¨ller, D., Schussmann, K., Pentrup, A., Shurzinske, L.

Journal:

Atherosclerosis

Year:

1994

Language:

english

File:

PDF, 162 KB

english, 1994

14

1.5 Efficacy and Safety of Dulaglutide vs. Metformin in Type 2 Diabetes (AWARD-3) (69-OR)

Umpierrez, Guillermo E., Manghi, Federico P., Povedano, Santiago Tofe, Shurzinske, Linda, Pechtner, Valeria

Journal:

Nederlands Tijdschrift voor Diabetologie

Year:

2013

File:

PDF, 93 KB

2013

15

Blinded Sample Size Adjustment

Bristol, D. R., Shurzinske, L.

Journal:

Drug Information Journal

Year:

2001

Language:

english

File:

PDF, 466 KB

english, 2001

16

Adjusting for Baseline on the Analysis of Repeated Binary Responses with Missing Data

Jiang, Honghua, Kulkarni, Pandurang M, Mallinckrodt, Craig H, Shurzinske, Linda, Molenberghs, Geert, Lipkovich, Ilya

Journal:

Statistics in Biopharmaceutical Research

Year:

2015

Language:

english

File:

PDF, 541 KB

english, 2015

17

Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease

Pitt, Bertram, Waters, David, Brown, William Virgil, van Boven, Ad J., Schwartz, Leonard, Title, Lawrence M., Eisenberg, Daniel, Shurzinske, Linda, McCormick, Lisa S.

Journal:

Boston Medical and Surgical Journal

Year:

1999

Language:

english

File:

PDF, 103 KB

english, 1999

18

An Evaluation of Estrogen and Atorvastatin, A New H.MGRI, in Hypercholesterolemic Postmenopausal Women

Heinonen, Therese M, Schrott, Helmut, Broyles, Frances, Shurzinske, Linda, Black, Donald M

Journal:

Year:

1996

File:

PDF, 231 KB

1996

19

Differential effects of once weekly GLP-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardised test meal in patients with type 2 diabetes

Mari, Andrea, Del Prato, Stefano, Ludvik, Bernhard, Milicevic, Zvonko, de la Peña, Amparo, Shurzinske, Linda, Karanikas, Chrisanthi A., Pechtner, Valeria

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 307 KB

english, 2016

20

Network meta-analysis accurately predicted the outcome of a subsequent randomised trial comparing once weekly dulaglutide 1.5 mg and once daily liraglutide 1.8 mg

Fahrbach, J. L., Fu, H., Shurzinske, L., Skrivanek, Z., Martin, S.

Journal:

International Journal of Clinical Practice

Year:

2016

Language:

english

File:

PDF, 173 KB

english, 2016

21

Legacy effects of drought alters the aquatic food web of a northern boreal peatland

DeColibus, Dawn T., Rober, Allison R., Sampson, Avery M., Shurzinske, Amanda C., Walls, Jeremy T., Turetsky, Merritt R., Wyatt, Kevin H.

Journal:

Freshwater Biology

Year:

2017

Language:

english

File:

PDF, 1.24 MB

english, 2017

22

Efficacy and Safety of a New Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitor, Atorvastatin, in Patients with Combined Hyperlipidemia: Comparison with Fenofibrate

Ooi, Teik C., Heinonen, Therese, Alaupovic, Petar, Davignon, Jean, Leiter, Lawrence, Lupien, Paul J., Sniderman, Allan D., Tan, Meng H., Tremblay, Gerald, Sorisky, Alexander, Shurzinske, Linda, Black,

Journal:

Arteriosclerosis Thrombosis and Vascular Biology

Year:

1997

File:

PDF, 713 KB

1997

23

Defining estimands using a mix of strategies to handle intercurrent events in clinical trials

Qu, Yongming, Shurzinske, Linda, Sethuraman, Shanthi

Journal:

Pharmaceutical Statistics

Year:

2020

File:

PDF, 661 KB

2020

24

Do enzymatic analyses of serum triglycerides really need blanking for free glycerol?

Uprichard, A C G, Shurzinske, L, Watts, A R, Nawrocki, J W

Journal:

Clinical Chemistry

Year:

1991

File:

PDF, 540 KB

1991

25

Dulaglutide in Diabetes and Chronic Kidney Disease: AWARD-7 Exploratory Analysis of Clinical Outcomes

Tuttle, Katherine R., Rayner, Brian, Lakshmanan, Mark C., Kwan, Anita Y.M., Konig, Manige, Shurzinske, Linda, Botros, Fady T.

Journal:

Year:

2020

File:

PDF, 534 KB

2020